UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 28, 2023

Accession Number:	0001193125-23-056275
Submission Type:	POS AM
CIK: 0001699382 Company Name: PMV Pharmaceuticals, Inc. File Number: 333-260012